85 related articles for article (PubMed ID: 7585587)
1. Relaxin activates the L-arginine-nitric oxide pathway in human breast cancer cells.
Bani D; Masini E; Bello MG; Bigazzi M; Sacchi TB
Cancer Res; 1995 Nov; 55(22):5272-5. PubMed ID: 7585587
[TBL] [Abstract][Full Text] [Related]
2. Relaxin and breast cancer.
Bani D
Bull Cancer; 1997 Feb; 84(2):179-82. PubMed ID: 9180842
[TBL] [Abstract][Full Text] [Related]
3. Relaxin up-regulates inducible nitric oxide synthase expression and nitric oxide generation in rat coronary endothelial cells.
Failli P; Nistri S; Quattrone S; Mazzetti L; Bigazzi M; Sacchi TB; Bani D
FASEB J; 2002 Feb; 16(2):252-4. PubMed ID: 11744624
[TBL] [Abstract][Full Text] [Related]
4. Relaxin depresses platelet aggregation: in vitro studies on isolated human and rabbit platelets.
Bani D; Bigazzi M; Masini E; Bani G; Sacchi TB
Lab Invest; 1995 Nov; 73(5):709-16. PubMed ID: 7474945
[TBL] [Abstract][Full Text] [Related]
5. Relaxin potentiates the expression of inducible nitric oxide synthase by endothelial cells from human umbilical vein in in vitro culture.
Quattrone S; Chiappini L; Scapagnini G; Bigazzi B; Bani D
Mol Hum Reprod; 2004 May; 10(5):325-30. PubMed ID: 15026539
[TBL] [Abstract][Full Text] [Related]
6. Relaxin activates the L-arginine-nitric oxide pathway in vascular smooth muscle cells in culture.
Bani D; Failli P; Bello MG; Thiemermann C; Bani Sacchi T; Bigazzi M; Masini E
Hypertension; 1998 Jun; 31(6):1240-7. PubMed ID: 9622136
[TBL] [Abstract][Full Text] [Related]
7. L-arginine inhibits apoptosis via a NO-dependent mechanism in Nb2 lymphoma cells.
Dodd F; Limoges M; Boudreau RT; Rowden G; Murphy PR; Too CK
J Cell Biochem; 2000 Apr; 77(4):624-34. PubMed ID: 10771518
[TBL] [Abstract][Full Text] [Related]
8. eNOS, nNOS, cGMP and protein kinase G mediate the inhibitory effect of pancreastatin, a chromogranin A-derived peptide, on growth and proliferation of hepatoma cells.
Díaz-Troya S; Najib S; Sánchez-Margalet V
Regul Pept; 2005 Feb; 125(1-3):41-6. PubMed ID: 15582712
[TBL] [Abstract][Full Text] [Related]
9. Regulation of the inducible cyclo-oxygenase pathway in human cultured airway epithelial (A549) cells by nitric oxide.
Watkins DN; Garlepp MJ; Thompson PJ
Br J Pharmacol; 1997 Aug; 121(7):1482-8. PubMed ID: 9257931
[TBL] [Abstract][Full Text] [Related]
10. The role of nitric oxide in L-arginine-stimulated growth hormone release.
Fisker S; Nielsen S; Ebdrup L; Bech JN; Christiansen JS; Pedersen EB; Jørgensen JO
J Endocrinol Invest; 1999; 22(5 Suppl):89-93. PubMed ID: 10442577
[TBL] [Abstract][Full Text] [Related]
11. Relaxin does not influence the growth of human cervical adenocarcinoma (HeLa) cells in culture.
Rho YS; Min G
Ann N Y Acad Sci; 2005 May; 1041():470-80. PubMed ID: 15956748
[TBL] [Abstract][Full Text] [Related]
12. Altered nitric oxide production and exogenous nitric oxide do not affect the proliferation of rat mesangial cells.
Mohaupt M; Schoecklmann HO; Schulze-Lohoff E; Sterzel RB
J Hypertens; 1994 Apr; 12(4):401-8. PubMed ID: 8064164
[TBL] [Abstract][Full Text] [Related]
13. Accessibility of endothelial and inducible nitric oxide synthase to the intracellular citrulline-arginine regeneration pathway.
Shen LJ; Beloussow K; Shen WC
Biochem Pharmacol; 2005 Jan; 69(1):97-104. PubMed ID: 15588718
[TBL] [Abstract][Full Text] [Related]
14. Arginase activity in human breast cancer cell lines: N(omega)-hydroxy-L-arginine selectively inhibits cell proliferation and induces apoptosis in MDA-MB-468 cells.
Singh R; Pervin S; Karimi A; Cederbaum S; Chaudhuri G
Cancer Res; 2000 Jun; 60(12):3305-12. PubMed ID: 10866325
[TBL] [Abstract][Full Text] [Related]
15. Disparate effects of relaxin and TGFbeta1: relaxin increases, but TGFbeta1 inhibits, the relaxin receptor and the production of IGFBP-1 in human endometrial stromal/decidual cells.
Mazella J; Tang M; Tseng L
Hum Reprod; 2004 Jul; 19(7):1513-8. PubMed ID: 15155604
[TBL] [Abstract][Full Text] [Related]
16. Platelet-activating factor augments lipopolysaccharide-induced nitric oxide formation by rat Kupffer cells.
Mustafa SB; Howard KM; Olson MS
Hepatology; 1996 Jun; 23(6):1622-30. PubMed ID: 8675186
[TBL] [Abstract][Full Text] [Related]
17. Modulation of arginine metabolic pathways as the potential anti-tumor mechanism of recombinant arginine deiminase.
Shen LJ; Beloussow K; Shen WC
Cancer Lett; 2006 Jan; 231(1):30-5. PubMed ID: 16356828
[TBL] [Abstract][Full Text] [Related]
18. Protective effect of relaxin in cardiac anaphylaxis: involvement of the nitric oxide pathway.
Masini E; Zagli G; Ndisang JF; Solazzo M; Mannaioni PF; Bani D
Br J Pharmacol; 2002 Oct; 137(3):337-44. PubMed ID: 12237253
[TBL] [Abstract][Full Text] [Related]
19. N-(4-Hydroxyphenyl)retinamide and nitric oxide pro-drugs exhibit apoptotic and anti-invasive effects against bone metastatic breast cancer cells.
Simeone AM; Colella S; Krahe R; Johnson MM; Mora E; Tari AM
Carcinogenesis; 2006 Mar; 27(3):568-77. PubMed ID: 16199439
[TBL] [Abstract][Full Text] [Related]
20. Ghrelin induces growth hormone secretion via a nitric oxide/cGMP signalling pathway.
Rodríguez-Pacheco F; Luque RM; Tena-Sempere M; Malagón MM; Castaño JP
J Neuroendocrinol; 2008 Mar; 20(3):406-12. PubMed ID: 18208548
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
